← Back to Search

Artificial Tears

FreshKote for Dry Eye Syndrome

Phase 4
Waitlist Available
Led By Mitch Jackson, MD
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights

Study Summary

The purpose of this study is to compare the efficacy of FreshKote and Systane for the reduction of dry eye signs and symptoms.

Eligible Conditions
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Best Corrected Visual Acuity
TBUT

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: FreshKoteActive Control1 Intervention
Group II: SystanePlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,588 Total Patients Enrolled
Mitch Jackson, MDPrincipal InvestigatorJackson Eye, S.C
1 Previous Clinical Trials
60 Total Patients Enrolled
Jay Pepose, MDPrincipal InvestigatorPepose Vision Institute
1 Previous Clinical Trials
200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby May 2025